Published in Infect Immun on June 01, 1980
A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature (2013) 3.55
Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. J Clin Microbiol (1983) 3.20
Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures. J Clin Microbiol (1984) 1.61
Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol (1992) 1.56
Combined immunoaffinity cDNA-RNA hybridization assay for detection of hepatitis A virus in clinical specimens. J Clin Microbiol (1985) 1.35
Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol (1987) 1.22
Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol (1981) 1.17
Nosocomial hepatitis A infection in a paediatric intensive care unit. Arch Dis Child (1987) 1.11
Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles. J Virol (1993) 1.00
Detection of hepatitis A virus and antibody by solid-phase radioimmunoassay and enzyme-linked immunosorbent assay with monoclonal antibodies. J Clin Microbiol (1985) 0.98
Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay. J Clin Microbiol (1988) 0.97
Genomic heterogeneity among human and nonhuman strains of hepatitis A virus. J Virol (1987) 0.93
Increase in immunoglobulin M antibodies against gut bacteria during acute hepatitis A. Infect Immun (1983) 0.90
Pathology of hepatitis A infection in the owl monkey (Aotus trivirgatus). Am J Pathol (1984) 0.87
Solid-phase antibody capture hemadsorption assay for detection of hepatitis A virus immunoglobulin M antibodies. J Clin Microbiol (1993) 0.77
Hepatology. Postgrad Med J (1991) 0.75
Determination of immunoglobulin M antibodies against hepatitis B core antigen and hepatitis A virus by reorienting sucrose gradient high-speed centrifugation for diagnosis of acute viral-hepatitis. J Clin Microbiol (1981) 0.75
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
A new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A. J Med Virol (1979) 4.40
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53
A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus. J Infect Dis (1979) 3.15
Specific detection of IgM-antibodies by ELISA, applied in hepatitis-A. Lancet (1978) 2.89
Selective detection of IgM-antibody against core antigen of the hepatitis B virus by a modified enzyme immune assay. J Med Virol (1979) 2.68
Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay. J Clin Microbiol (1978) 2.64
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Specific immune adherence assay for human hepatitis A antibody application to diagnostic and epidemiologic investigations. Proc Soc Exp Biol Med (1975) 2.38
Viral hepatitis. Clinical and tissue culture studies. JAMA (1970) 2.20
A solid-phase immunosorbent technique for the rapid detection of rubella IgM by haemagglutination inhibition. J Gen Virol (1979) 2.10
Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay. J Clin Microbiol (1977) 1.80
Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus. J Clin Microbiol (1979) 1.60
Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A-specific immunoglobulin M. J Clin Microbiol (1979) 1.60
Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest (1977) 1.42
The antibody response following hepatitis A infection. Intervirology (1977) 1.41
Determination of antisera titres ing the single radial immunodiffusion method. Immunochemistry (1969) 1.35
Viral hepatitis. Immunoglobulin response during the course of the disease. JAMA (1969) 1.18
Immunoglobulin M anti-hepatitis A virus determination reorienting gradient centrifugation for diagnosis of Acute Hepatitis A. J Clin Microbiol (1979) 1.10
Serodiagnosis of hepatitis B virus infection by antibody to core antigen. J Infect Dis (1977) 1.07
Fecal excretion of hepatitis A virus in humans. J Infect Dis (1977) 0.87
Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA (1993) 4.75
Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res (1992) 4.58
Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. J Clin Microbiol (1983) 3.20
Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA (1996) 3.14
Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology (1996) 3.14
A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol (1999) 3.13
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
Drug interactions in dermatologic surgery. J Dermatol Surg Oncol (1992) 2.94
Type A viral hepatitis. New developments in an old disease. N Engl J Med (1985) 2.86
Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr (1990) 2.84
The 5' nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J Virol (1991) 2.83
The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication. RNA (1998) 2.61
Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57
Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc Natl Acad Sci U S A (1990) 2.52
Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology (1988) 2.51
Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol (1985) 2.20
Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med (1982) 2.07
Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology (2000) 2.05
Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA (1985) 2.03
The global topography of Mars and implications for surface evolution. Science (1999) 2.02
Prevention of endemic HAA-positive hepatitis with gamma globulin. Use of a simple radioimmune assay to detect HAA. N Engl J Med (1972) 2.00
Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00
Transmission of hepatitis A virus among recently captured Panamanian owl monkeys. J Med Virol (1982) 1.94
Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J Virol (1996) 1.85
Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol Immunol (2000) 1.78
The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs. RNA (2001) 1.77
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 1.75
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol (1992) 1.73
A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet (1986) 1.61
Replication of EBV in epithelial cells during infectious mononucleosis. Nature (1977) 1.61
Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures. J Clin Microbiol (1984) 1.61
Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol (2001) 1.59
Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes. J Biol Chem (1993) 1.58
Horizontal transmission of hepatitis B virus. Lancet (1989) 1.57
Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol (1992) 1.56
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene (2011) 1.56
Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol (1974) 1.48
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47
Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization. J Virol (1996) 1.46
Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis (1977) 1.46
Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol (1998) 1.44
Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44
Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J Biol Chem (1996) 1.40
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA. J Virol (1993) 1.40
Shock syndrome in primary dengue infections. Am J Trop Med Hyg (1976) 1.38
Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA (1990) 1.37
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J Infect Dis (1988) 1.37
Combined immunoaffinity cDNA-RNA hybridization assay for detection of hepatitis A virus in clinical specimens. J Clin Microbiol (1985) 1.35
Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis (1980) 1.35
Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol (1996) 1.34
Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33
Antigenic relatedness of two strains of hepatitis A virus determined by cross-neutralization. Infect Immun (1983) 1.29
Mutational analysis of the GB virus B internal ribosome entry site. J Virol (2000) 1.29
Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol (1996) 1.29
Early events in naphthalene-induced acute Clara cell toxicity: comparison of membrane permeability and ultrastructure. Am J Respir Cell Mol Biol (1999) 1.28
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun (1981) 1.28
A military community outbreak of hepatitis type A related to transmission in a child care facility. Am J Epidemiol (1980) 1.27
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. J Infect Dis (1983) 1.27
Experimental infection of the New World owl monkey (Aotus trivirgatus) with hepatitis A virus. Infect Immun (1983) 1.27
Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol (1990) 1.25
An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect. Virology (1995) 1.24
Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin. Gastroenterology (1985) 1.24
Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol (2000) 1.22
Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol (1987) 1.22
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J Infect Dis (1984) 1.20
Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions. J Gen Virol (1985) 1.18
Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci U S A (1988) 1.18
Double autosomal trisomy (trisomy D+G) with mosaicism. J Med Genet (1969) 1.17
Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity. J Clin Invest (1987) 1.17
Immunoblot analysis demonstrates that the large and small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences. J Gen Virol (1992) 1.16
Simultaneous infection with multiple herpesviruses. Am J Med (1979) 1.15
Serum neutralizing antibody response to hepatitis A virus. J Infect Dis (1983) 1.15
Structural basis of the oligomerization of hepatitis delta antigen. Structure (1998) 1.14
Recent advances in hepatitis A vaccine development. Virus Res (1990) 1.13
Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA (1985) 1.13
Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am J Trop Med Hyg (1987) 1.13
Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin. J Infect Dis (1987) 1.12
Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis (1995) 1.12
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. Am J Trop Med Hyg (1984) 1.11
Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med (1986) 1.10
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology (1995) 1.09
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans. Am J Trop Med Hyg (1990) 1.08
Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther (1999) 1.06
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol (2000) 1.06
Adsorption and degradation of the weak acid mesotrione in soil and environmental fate implications. J Environ Qual (2002) 1.06
Identification of a voltage-dependent anion channel in the apical membrane of a Cl(-)-secretory epithelium (MDCK). Pflugers Arch (1985) 1.05
Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. J Infect Dis (1987) 1.05
Hepatitis delta virus mutant: effect on RNA editing. J Virol (1995) 1.05
Na(+)-independent, H(+)-coupled transepithelial beta-alanine absorption by human intestinal Caco-2 cell monolayers. J Biol Chem (1993) 1.05